Vanila Singh

Vanila M. Singh is an American physician and professor with involvement in United States health policy. Singh was a candidate for the United States House of Representatives in 2014. and she is currently an associate professor of anesthesiology, perioperative and pain medicine at Stanford University Medical Center. On June 12, 2017, She served as Chair of the Inter-Agency Pain Management Task Force established by the CARA Act of 2016, which released its final report on acute and chronic pain management best practices on May 30, 2019. Dr. Singh was also appointed as the Acting Regional Health Administrator in Region 9 (California, Arizona, Nevada, Hawaii and six Pacific Islands) in August 2018.

With various Republican Party endorsements, in early 2014 Singh announced a campaign against incumbent Mike Honda to represent California's 17th congressional district (Silicon Valley) in the US House of Representatives. In the primaries Singh came in third In 2016, she was a California delegate at the Republican National Convention in Cleveland.

Singh is vice chairman of the National Physicians Council on Health Policy. In 2016 she was named to the editorial board of Interventional Pain Letters. For 2016 and 2017, she was named chair of the professional standards/conduct committee of the Santa Clara County Medical Association.

Early life and education Vanila M. Singh was born in Bikaner, India. At age one The family moved to California when she was four years old, for anesthesiology, perioperative and pain medicine.

U.S. Department of Health and Human Services Dr. Singh was named Chief Medical Officer for the Office of the Assistant Secretary for Health at the U.S. Department of Health and Human Services (HHS) on June 12, 2017, as the primary medical advisor to the Assistant Secretary for Health on the development and implementation of HHS-wide public health policy recommendations, and guiding the national policy on opioids. The task force published its report on May 30, 2019,

She was also appointed as the Acting Regional Health Administrator for Region 9 (California, Arizona, Nevada, Hawaii and six Pacific Islands) in August 2018. She was appointed as an independent board of directors member for BioDelivery Sciences, International (NASDAQ: BDSI), a specialty pharmaceutical company focused on the treatment of serious and debilitating chronic conditions. Dr. Singh is also an independent board member for Virpax Pharmaceuticals Inc., a company developing novel drug delivery systems for pain management.

Media coverage Dr. Singh is a frequent contributor on local and national TV covering the COVID-19 pandemic. She has appeared on Fox Business' Neil Cavuto: Coast to Coast, Newsy Tonight with Chance Seales, and FOX KTVU. She has penned several op-eds on COVID-19, pain management policies, mental health, and illicit drugs which have been published in The Hill, Washington Post, STAT, and American Military News. Dr. Singh has also been profiled in Silicon Valley Magazine and Practical Pain Management.

2014 election In January 2014 As campaign points

Personal life A resident of the Bay Area of California, Singh is married On February 28, 2020, she was awarded the Philipp M. Lippe award from the American Academy of Pain Medicine for outstanding contributions to the social and political aspects of pain medicine. In 2018, Singh was awarded the Lifetime Achievement Award by the American Society of Interventional Pain Physicians.